Cite
Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study.
MLA
Ma, Yuyu, et al. “Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study.” Journal of Oncology, vol. 2022, Sept. 2022, pp. 1–10. EBSCOhost, https://doi.org/10.1155/2022/7839041.
APA
Ma, Y., Duan, F., Zhuang, Y., Song, C., Huang, J., Xia, W., Hong, R., Zheng, Q., Wang, S., Shi, Y., Xu, F., Yuan, Z., & Bi, X. (2022). Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study. Journal of Oncology, 2022, 1–10. https://doi.org/10.1155/2022/7839041
Chicago
Ma, Yuyu, Fangfang Duan, Yue Zhuang, Chenge Song, Jiajia Huang, Wen Xia, Ruoxi Hong, et al. 2022. “Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study.” Journal of Oncology 2022 (September): 1–10. doi:10.1155/2022/7839041.